391 related articles for article (PubMed ID: 24189571)
1. Insulin-like growth factor - oestradiol crosstalk and mammary gland tumourigenesis.
Hawsawi Y; El-Gendy R; Twelves C; Speirs V; Beattie J
Biochim Biophys Acta; 2013 Dec; 1836(2):345-53. PubMed ID: 24189571
[TBL] [Abstract][Full Text] [Related]
2. Interactions between the oestrogen and insulin-like growth factor signalling pathways in the control of breast epithelial cell proliferation.
Westley BR; Clayton SJ; Daws MR; Molloy CA; May FE
Biochem Soc Symp; 1998; 63():35-44. PubMed ID: 9513709
[TBL] [Abstract][Full Text] [Related]
3. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
4. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
Iida M; Tsuboi K; Niwa T; Ishida T; Hayashi SI
Breast Cancer; 2019 May; 26(3):272-281. PubMed ID: 30328006
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
6. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
Bradley LM; Gierthy JF; Pentecost BT
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
[TBL] [Abstract][Full Text] [Related]
7. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
8. Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II).
Brünner N; Yee D; Kern FG; Spang-Thomsen M; Lippman ME; Cullen KJ
Eur J Cancer; 1993; 29A(4):562-9. PubMed ID: 8435211
[TBL] [Abstract][Full Text] [Related]
9. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.
Duss S; André S; Nicoulaz AL; Fiche M; Bonnefoi H; Brisken C; Iggo RD
Breast Cancer Res; 2007; 9(3):R38. PubMed ID: 17573968
[TBL] [Abstract][Full Text] [Related]
10. Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.
Martin LA; Farmer I; Johnston SR; Ali S; Dowsett M
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S75-84. PubMed ID: 16113101
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen and insulin-like growth factors during the reproduction and growth of the tilapia Oreochromis niloticus and their interactions.
Baroiller JF; D'Cotta H; Shved N; Berishvili G; Toguyeni A; Fostier A; Eppler E; Reinecke M
Gen Comp Endocrinol; 2014 Sep; 205():142-50. PubMed ID: 25058367
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of c-Src blocks oestrogen-induced apoptosis and restores oestrogen-stimulated growth in long-term oestrogen-deprived breast cancer cells.
Fan P; Agboke FA; McDaniel RE; Sweeney EE; Zou X; Creswell K; Jordan VC
Eur J Cancer; 2014 Jan; 50(2):457-68. PubMed ID: 24183378
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
Chan TW; Pollak M; Huynh H
Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between the insulin-like growth factors and estrogens in breast cancer.
Yee D; Lee AV
J Mammary Gland Biol Neoplasia; 2000 Jan; 5(1):107-15. PubMed ID: 10791773
[TBL] [Abstract][Full Text] [Related]
16. Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
Saha T; Makar S; Swetha R; Gutti G; Singh SK
Eur J Med Chem; 2019 Sep; 177():116-143. PubMed ID: 31129450
[TBL] [Abstract][Full Text] [Related]
17. Measuring IGF-1, ER-α and EGFR expression can predict tamoxifen-resistance in ER-positive breast cancer.
Chong K; Subramanian A; Sharma A; Mokbel K
Anticancer Res; 2011 Jan; 31(1):23-32. PubMed ID: 21273576
[TBL] [Abstract][Full Text] [Related]
18. SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice.
Li H; Rajendran GK; Liu N; Ware C; Rubin BP; Gu Y
Breast Cancer Res; 2007; 9(1):R1. PubMed ID: 17201918
[TBL] [Abstract][Full Text] [Related]
19. Interaction between estrogen receptor alpha and insulin/IGF signaling in breast cancer.
Lanzino M; Morelli C; Garofalo C; Panno ML; Mauro L; Andò S; Sisci D
Curr Cancer Drug Targets; 2008 Nov; 8(7):597-610. PubMed ID: 18991569
[TBL] [Abstract][Full Text] [Related]
20. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
